Invention Grant
- Patent Title: Treatment of EBV and KHSV infection
- Patent Title (中): 治疗EBV和KHSV感染
-
Application No.: US10326444Application Date: 2002-12-19
-
Publication No.: US07211570B2Publication Date: 2007-05-01
- Inventor: Raymond F. Schinazi , Junxing Shi , Joyce D. Fingeroth , Erik Gustafson
- Applicant: Raymond F. Schinazi , Junxing Shi , Joyce D. Fingeroth , Erik Gustafson
- Applicant Address: US NJ Princeton US GA Atlanta US MA Boston
- Assignee: Pharmasset, Inc.,Emory University,Beth Israel Deaconess Medical Center
- Current Assignee: Pharmasset, Inc.,Emory University,Beth Israel Deaconess Medical Center
- Current Assignee Address: US NJ Princeton US GA Atlanta US MA Boston
- Agency: Merchant & Gould
- Main IPC: A61K31/70
- IPC: A61K31/70 ; A01N43/06 ; A01N43/26 ; A01N47/10 ; A01N43/54
Abstract:
A method and composition for the treatment, prevention and/or prophylaxis of a host, and in particular, a human, infected with Epstein-Barr virus (EBV), is provided that includes administering an effective amount of a 5-substituted uracil nucleoside or its pharmaceutically acceptable salt or prodrug, optionally in a pharmaceutically acceptable diluent or excipient.
Public/Granted literature
- US20030176392A1 Treatment of EBV and KHSV infection and associated abnormal cellular proliferation Public/Granted day:2003-09-18
Information query
